Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Loebstein

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Potential dosing errors using portable prothrombin time monitoring devicesRonen Loebstein, Daniel Kurnik, Aharon Lubetsky, et al.
Autoimmunity Reviews|April 23, 2016
Methotrexate toxicity-responseShaye Kivity, Yaron Zafrir, Ronen Loebstein, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
Blood|March 26, 2008
VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individualsEleni Aklillu, Cheryl Leong, Ronen Loebstein, et al.
Thrombosis Research|October 16, 2020
Uninterrupted direct oral anticoagulant treatment during acute illness: Impact on clinical outcomesItai Gueta, Yehoshua Nadav Schacham, Noa Markovits, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 30, 2008
Database assessment of the effectiveness of brand versus generic rosiglitazone in patients with type 2 diabetes mellitusRonen Loebstein, Itzhak Katzir, Janet Vasterman-Landes, et al.
Thrombosis and Haemostasis|July 24, 2003
Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulationAharon Lubetsky, Yigal Shasha, David Olchovsky, et al.
Health Systems (Basingstoke, England)|February 20, 2026
Accessibility of big data in medicine: adjusting the duration of antibiotic treatment for gram-negative bloodstream infectionsLiat Toderis, Iris Reychav, Roger McHaney, et al.
Clinical Pharmacology and Therapeutics|September 11, 2003
Increased warfarin doses and decreased international normalized ratio response after nationwide generic switchingHillel Halkin, Jonathan Shapiro, Daniel Kurnik, et al.
Thrombosis and Haemostasis|November 16, 2004
Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trialDaniel Kurnik, Ronen Loebstein, Hadas Rabinovitz, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Potential dosing errors using portable prothrombin time monitoring devicesRonen Loebstein, Daniel Kurnik, Aharon Lubetsky, et al.
Autoimmunity Reviews|April 23, 2016
Methotrexate toxicity-responseShaye Kivity, Yaron Zafrir, Ronen Loebstein, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
Blood|March 26, 2008
VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individualsEleni Aklillu, Cheryl Leong, Ronen Loebstein, et al.
Thrombosis Research|October 16, 2020
Uninterrupted direct oral anticoagulant treatment during acute illness: Impact on clinical outcomesItai Gueta, Yehoshua Nadav Schacham, Noa Markovits, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 30, 2008
Database assessment of the effectiveness of brand versus generic rosiglitazone in patients with type 2 diabetes mellitusRonen Loebstein, Itzhak Katzir, Janet Vasterman-Landes, et al.
Thrombosis and Haemostasis|July 24, 2003
Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulationAharon Lubetsky, Yigal Shasha, David Olchovsky, et al.
Health Systems (Basingstoke, England)|February 20, 2026
Accessibility of big data in medicine: adjusting the duration of antibiotic treatment for gram-negative bloodstream infectionsLiat Toderis, Iris Reychav, Roger McHaney, et al.
Clinical Pharmacology and Therapeutics|September 11, 2003
Increased warfarin doses and decreased international normalized ratio response after nationwide generic switchingHillel Halkin, Jonathan Shapiro, Daniel Kurnik, et al.
Thrombosis and Haemostasis|November 16, 2004
Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trialDaniel Kurnik, Ronen Loebstein, Hadas Rabinovitz, et al.
Pageof 7